PL | EN

Longevity Health System

Trade Mark (LHS®) – vision, mission and investment goal

The world's first fully integrated, AI-orchestrated healthcare system – combining patient-centered care, hospital as a service (AI Hospital), the personal AMIGOO token and value-based financing.

Vision

To build the world's first fully integrated, AI-orchestrated healthcare system that combines:

Integrated care as a service

Patient-centered, coordinated care delivered in an "as a Service" model.

AI Hospital as a Service

Hospital as a service – an ambulatory hub & spoke model orchestrated by AI.

AMIGOO® token

A patented personal token, MiCA-compliant (utility token) – a digital key to access the PSZ ecosystem's services.

Value-based financing (PVHS)

A Value-Based Healthcare model with dedicated settlement instruments and outcome-based rewards.

Predictive healthspan optimization

Extending healthy life through prevention and predictive analytics.

Clinical trials with Digital Twin

A research ecosystem supported by digital twins and generative AI models (FusionAI).

Longevity Technology Park – under organization (BioMedTech International).

Mission

Transforming siloed, analog, reactive medicine into digital, proactive, precise, participatory and preventive (4P) medicine – delivered globally through scalable licensing, strategic partnerships and dedicated investment instruments, supported by state-of-the-art technologies.

Executive Summary

Longevity Health System (LHS) is the world's first fully integrated, AI-orchestrated healthcare ecosystem combining: People-Centred Integrated Care as a Service, AI Hospital as a Service (an ambulatory hub & spoke model), the personal AMIGOO token (patent pending) and a Value-Based Payment model with dedicated CMS codes.

Market problems & window of opportunity

Current healthcare systems are reactive, episodic and fee-for-service. This leads to:

Late disease detection

Diagnosis usually at an advanced stage, when treatment is costlier and less effective.

No incentive for prevention

Low adherence and a lack of incentives for preventive action by patients.

Huge cost of lifestyle diseases

A growing burden on the system from chronic disease treatment.

Low clinical-trial efficiency

Recruitment difficulties and a lack of real-world data.

Biased data for AI

Algorithms based on incomplete, historical and biased data.

Interested in partnership or investment?

Get in touch to learn about the Longevity Health System model, the PSZ ecosystem and partnership and financing opportunities.

Write to us